Global E-Health Forum: Designing Personalized Healthcare

11 - 13 October 2011, Hamburg, Germany.
Dr. Eric M. Liederman (Director of Medical Informatics, The Permanente Medical Group, U.S.A.) has confirmed his keynote at this year's Global E-Health Forum. He will present "Balancing Privacy Protection with Patient Care".

Healthcare organizations are under increasing regulatory pressure to improve the quality and safety of care and to protect patient privacy. Electronic Health Records (EHR) provide a vehicle to improve care, however concerns over protecting the system against privacy violations are a significant challenge. Dr. Eric Liederman will discuss how to achieve a balance between protecting privacy and security, and fostering high quality patient care.

Learn how Kaiser Permanente's "trust, but hold accountable" approach using forensic mining of its EHR audit databases, resulted in a > 90% reduction in privacy violations over several weeks. Learn how deterrence methods have also helped clinicians and staff avoid giving in to career-ending temptation.

Canada is Partner Country
Mr. Peter M. Boehm, Ambassador of Canada in Germany is pleased to endorse the Global E-Health Forum in Hamburg. He states: "Developing successful e-health solutions requires combining knowledge and technology in several key areas, including: enabling electronic communications infrastructure; providing remote communities in Canada with access to clinical and non-clinical healthcare professionals through the use of advanced information communications technologies; improving health information systems to support service delivery including virtual health libraries; and upholding the health privacy of patients through high standards of information management and exchange." For full text, please see http://www.global-ehealth-forum.com/canada/.

Transforming healthcare in Canada through e-health, the challenges facing the health system in Canada and the role of information and information technology within a reformed health system - these are the topics Richard C. Alvarez, President and Chief Executive Officer, Canada Health Infoway, will address in his keynote.

Program
The first two conference days at the Hamburg Chamber of Commerce will feature more speakers from all over the globe. Their strategy presentations and case studies will be complemented by discussion forums, workshops and an exhibition of solution providers. The official reception for the conference delegates will take place in the U.S. Consulate General ("the little White House at the lake Alster") on October 11. The third day is dedicated to various breakout sessions and guided tours at different locations (among others hospitals) targeting the individual information needs of special interest groups.

Registration
Register by August 30 for a conference fee of Euro 599 incl. VAT. The fee includes the admission to all conference sessions, lunches, coffee breaks and the evening reception on October 11, 2011.

For further information, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

Study finds lack of racial diversity in cancer dru…

New research published in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study - conducted by researchers from UBC...

Preventing tumor metastasis

Researchers at the Paul Scherrer Institute, together with colleagues from the pharmaceutical company F. Hoffmann-La Roche AG, have taken an important step towards the dev...

A new drug could revolutionize the treatment of ne…

The international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc. has found a potential drug that may pre...

Interactions discovered in cells insulating nerve …

Schwann cells form a protective sheath around nerve fibres and ensure that nerve impulses are transmitted rapidly. If these cells are missing or damaged, severe neurologi...

Anniversary of the pivotal RE-LY® trial marks a de…

Boehringer Ingelheim today announces the ten-year anniversary of the RE-LY® trial publication(1-3) recognising the contribution made in the decade since by patients, heal...

AstraZeneca agrees to buy US FDA Priority Review V…

AstraZeneca announced that it has agreed to buy a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) for a total cash consideration of $95m from a subsid...

Breast cancer can form 'sleeper cells' after drug …

Breast cancer medicines may force some cancer cells into 'sleeper mode', allowing them to potentially come back to life years after initial treatment. These are the early...

Pfizer invests half billion dollars to advance sta…

Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina...

The Pfizer Foundation invests in 20 organizations …

The Pfizer Foundation announced 20 grants* to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to...

FDA grants Fast Track designation for Farxiga in c…

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to delay the ...

Amgen and Allergan announce positive top-line resu…

Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced positive top-line results from a comparative clinical study evaluating the efficacy and safety of ABP 798...

Experimental validation confirms the ability of ar…

Insilico Medicine, a global leader in artificial intelligence for drug discovery, announced the publication of a paper titled, "Deep learning enables rapid identification...